Kuang-Chi Technologies (002625) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
28 Apr, 2026Executive summary
Achieved revenue of ¥2.05 billion in 2025, up 31.32% year-over-year; net profit attributable to shareholders reached ¥687 million, up 5.37% year-over-year.
Core business in metamaterial structural components for advanced equipment, with significant growth in both product and R&D service revenue.
Maintained industry leadership as the only domestic company with large-scale metamaterial production and application.
Major contracts executed and new batch production contracts signed, supporting future revenue.
Financial highlights
Revenue: ¥2,045.7 million (+31.32% YoY); net profit attributable to shareholders: ¥686.95 million (+5.37% YoY).
Gross margin for metamaterial products: 52.22%; overall gross margin: 49.17%.
Operating cash flow: ¥808.38 million (up 1,039.81% YoY); significant improvement in cash generation.
R&D investment: ¥156.53 million (+24.90% YoY), representing 7.65% of revenue.
EPS: ¥0.32 (basic and diluted, +6.67% YoY); weighted average ROE: 7.40%.
Total assets: ¥11.88 billion (+19.81% YoY); net assets: ¥9.63 billion (+7.75% YoY).
Outlook and guidance
2026 plan focuses on high-quality growth, expanding metamaterial applications in core and civilian markets, and improving operational efficiency.
Continued investment in R&D and production capacity, with emphasis on the fifth-generation metamaterial technology and “Mass Production 2.0”.
Guidance to increase market penetration and accelerate the second growth curve in civilian sectors.
Latest events from Kuang-Chi Technologies
- Revenue and net profit rose strongly, but operating cash flow fell sharply amid major new contracts.002625
Q1 202629 Apr 2026 - Strong revenue and profit growth supported by major new contracts and robust demand.002625
Q3 202519 Dec 2025 - Net profit rose 20.33% year-over-year on stable revenue and strong contract wins.002625
Q2 202419 Dec 2025 - Net profit rose 11.77% to ¥652 million on 4.25% revenue growth, with strong R&D gains.002625
Q4 202419 Dec 2025 - Revenue and net profit rose, with strong margins and major new contracts signed.002625
Q2 202520 Aug 2025 - Net profit rose 19.48% year-over-year in Q3 2024, driven by robust metamaterials growth.002625
Q3 202413 Jun 2025 - Revenue and profit grew solidly in Q1 2025, driven by new metamaterial contracts.002625
Q1 20256 Jun 2025